Filing Details

Accession Number:
0001127602-17-022063
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-23 08:26:31
Reporting Period:
2017-06-22
Filing Date:
2017-06-23
Accepted Time:
2017-06-23 08:26:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1082554 United Therapeutics Corp UTHR Pharmaceutical Preparations (2834) 521984749
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1106578 A Martine Rothblatt C/O United Therapeutics Corporation
1040 Spring Street
Silver Spring MD 20910
Chairman & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-22 1,234 $30.75 1,374 No 4 M Direct
Common Stock Disposition 2017-06-22 834 $132.09 540 No 4 S Direct
Common Stock Disposition 2017-06-22 400 $132.79 140 No 4 S Direct
Common Stock Acquisiton 2017-06-22 943 $30.75 662,184 No 4 M Indirect By Trusts
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Indirect By Trusts
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2017-06-22 1,234 $0.00 1,234 $30.75
Common Stock Stock Options Disposition 2017-06-22 943 $0.00 943 $30.75
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
51,003 2009-12-26 2017-12-31 No 4 M Direct
50,060 2009-12-26 2017-12-31 No 4 M Direct
Footnotes
  1. This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person. The transaction was structured as a broker-assisted cashless exercise, such that the number of shares sold was limited to a sufficient number to cover the exercise price of the options and anticipated taxes. The remaining shares are held by a trust beneficially owned by the reporting person.
  2. Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.
  3. This transaction was executed in multiple trades at prices ranging from $131.55 to $132.51. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $132.68 to $133.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.